Improved glycemic control through continuous glucose sensor-augmented insulin pump therapy: Prospective results from a community and academic practice patient registry

Journal of Diabetes Science and Technology

Volumn 3, Issue 4, 2009, Pages 804-811

  Cohen, Ohad ^a   Körner, Anna ^b   Chlup, Rudolf ^c   Zoupas, Christos S ^d   Ragozin, Anton K ^e   Wudi, Krisztina ^f   Bartaskova, Dagmar ^g   Pappas, Aggelos ^h   Niederland, Tamás ⁱ   Taybani, Zoltán ^j   Barák, Lubomir ^k   Vazeou, Andriani ^l  

^a SHEBA MEDICAL CENTER   (Israel)

^b SOTE Clinic   (Hungary)

^c PALACKÝ UNIVERSITY   (Czech Republic)

^d HYGEIA HOSPITAL   (Greece)

^e PETROVSKY NATIONAL RESEARCH CENTER OF SURGERY   (Russian Federation)

^f Diabetes Department   (Hungary)

^g UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^h Venizelio Pananio Hospital of Heraklion   (Greece)

ⁱ Department of Pediatrics   (Hungary)

^j Rethy Pal Hospital   (Hungary)

^k UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

^l Aglaia Kuriakou Pediatric Hospital   (Greece)

more..

Author keywords

Continuous glucose sensing; Continuous subcutaneous insulin infusion; Everyday practice; Glycemic control; Hypoglycemic excursions; Patient registry

Indexed keywords

ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ADOLESCENT; ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BLOOD; BLOOD GLUCOSE MONITORING; CHILD; CLINICAL TRIAL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATIENT SELECTION; PROSPECTIVE STUDY; REGISTER; REGRESSION ANALYSIS; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; MONITORING, AMBULATORY; PATIENT SELECTION; PROSPECTIVE STUDIES; REGISTRIES; REGRESSION ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77953087303     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680900300429     Document Type: Article

References (24)

1. Klonoff DC. A review of continuous glucose monitoring technology. Diabetes Technol Ther. 2005;7(5):770-5.
2. Bromberg JS, LeRoith D. Diabetes cure - is the glass half full? N Engl J Med. 2006;355(13):1372-4.
3. Garg SK. Health impact from frequent and continuous glucose monitoring. Diabetes Technol Ther. 2004;6(4):523-4.
4. Reach G. Continuous glucose monitoring and diabetes health outcomes: a critical appraisal. Diabetes Technol Ther. 2008;10(2):69-80.
5. Wentholt IM, Hart AA, Hoekstra JB, Devries JH. How to assess and compare the accuracy of continuous glucose monitors? Diabetes Technol Ther. 2008;10(2):57-68.
6. Bode BW, Gross TM, Thornton KR, Mastrototaro JJ. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract. 1999;46(3):183-90.
7. Kaufman FR, Gibson LC, Halvorson M, Carpenter S, Fisher LK, Pitukcheewanont P. A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care. 2001;24(12):2030-4.
8. Kaufman FR, Austin J, Neinstein A, Jeng L, Halvorson M, Devoe DJ, Pitukcheewanont P. Nocturnal hypoglycemia detected with the Continuous Glucose Monitoring System in pediatric patients with type 1 diabetes. J Pediatr. 2002;141(5):625-30.
9. Ludvigsson J, Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics. 2003;111(5 Pt 1):933-8.
10. Garg SK, Schwartz S, Edelman SV. Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care. 2004;27(3):734-8.
11. Chase HP, Beck R, Tamborlane W, Buckingham B, Mauras N, Tsalikian E, Wysocki T, Weinzimer S, Kollman C, Ruedy K, Xing D. A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care. 2005;28(5):1101-6.
12. Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, Tubiana-Rufi N, Kerr D, Phillip M. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care. 2006;29(12):2730-2.
13. Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care. 2006;29(1):44-50.
14. Garg S, Jovanovic L. Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor. Diabetes Care. 2006;29(12):2644-9.
15. Bailey TS, Zisser HC, Garg SK. Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study. Diabetes Technol Ther. 2007;9(3):203-10.
16. Garg SK, Kelly WC, Voelmle MK, Ritchie PJ, Gottlieb PA, McFann KK, Ellis SL. Continuous home monitoring of glucose: improved glycemic control with real-life use of continuous glucose sensors in adult subjects with type 1 diabetes. Diabetes Care. 2007;30(12):3023-5.
17. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359(14):1464-76.
18. Hirsch I, Abelseth J, Bode BW, Fischer JS, Kaufman FR, Mastrototaro J, Parkin CG. Wolpert HA, Buckingham BA. Sensor augmented pump therapy: results of the first treat-to-target study. Diabetes Technol Ther. 2008;10(50:377-83.
19. Manley SE. Estimated average glucose derived from HbA1c eAG: report from European Association for the Study of Diabetes (EASD), Amsterdam 2007. Diabet Med. 2008;25(20:126-8.
20. Mastrototaro JJ, Cooper KW, Soundararajan G, Sanders JB, Shah RV. Clinical experience with an integrated continuous glucose sensor/insulin pump platform: a feasibility study. Adv Ther. 2006;23(5):725-32.
21. Danne T, Battelino T, Kordonouri O, Hanas R, Klinkert C, Ludvigsson J, Barrio R, Aebi C, Gschwend S, Mullis PE, Schumacher U, Zumsteg U, Morandi A, Rabbone I, Cherubini V, Toni S, de Beaufort C, Hindmarsh P, Sumner A, van Waarde WM, van den Berg N, Phillip M. A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries. Pediatr Diabetes. 2005;6(4):193-8.
22. Adair G. The Hawthorne effect: a reconsideration of the methodological artifact. J Appl Psychol. 1984;69:334-45.
23. Zoupas CS, Kefaloyannis N, Pappas A, Kepaptzologou O, Kyrlaki E, Giannakopolous TF, Garoutsou P, Vasilopolous H. Evaluation of continuous use of real-time glucose monitoring, alone and after combined insulin pump therapy, as a means to normalise glycaeic control in IDDM [abstract]. Diabetologia. 2007;50:s418.
24. Danne T, Battelino T, Jarosz-Chobot P, Kordonouri O, Pánkowska E, Ludvigsson J, Schober E, Kaprio E, Saukkonen T, Nicolino M, Tubiana-Rufi N, Klinkert C, Haberland H, Vazeou A, Madacsy L, Zangen D, Cherubini V, Rabbone I, Toni S, de Beaufort C, Bakker-van Waarde W, van den Berg N, Volkov I, Barrio R, Hanas R, Zumsteg U, Kuhlmann B, Aebi C, Schumacher U, Gschwend S, Hindmarsh P, Torres M, Shehadeh N, Phillip M; PedPump Study Group. Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries. Diabetologia. 2008;51(9):1594-601.